about
Myocardial Regional Interstitial Fibrosis is Associated With Left Intra-Ventricular Dyssynchrony in Patients With Heart Failure: A Cardiovascular Magnetic Resonance Study.Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis.Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure.KCNN2 polymorphisms and cardiac tachyarrhythmias.Everolimus-Eluting Bioresorbable Vascular Scaffold in Real World Practice - A Single Center Experience.Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients.Perfusion index derived from a pulse oximeter can detect changes in peripheral microcirculation during uretero-renal-scopy stone manipulation (URS-SM).Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models.Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis.Use of Extracorporeal Membrane Oxygenation to Rescue Patients With Refractory Ventricular Arrhythmia in Acute Myocardial Infarction.Left ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor.Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.Differential baseline expression and angiotensin II-stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive ratsGenome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillationNon-Carriers of Reduced-Function CYP2C19 Alleles are Most Susceptible to Impairment of the Anti-Platelet Effect of Clopidogrel by Proton-Pump Inhibitors: A Pilot Study.Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysisSerial heart rhythm complexity changes in patients with anterior wall ST segment elevation myocardial infarction.Angiotensin II regulates the LARG/RhoA/MYPT1 axis in rat vascular smooth muscle in vitro.TNF-α down-regulates sarcoplasmic reticulum Ca²⁺ ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-κB to promoter response element.Renin-angiotensin system gene polymorphisms predict the risk of stroke in patients with atrial fibrillation: a 10-year prospective follow-up study.Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.Prognostic significance of left ventricular diastolic function in burn patients.A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation.Genome-wide methylation profiles in coronary artery ectasia.Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.Association of low glomerular filtration rate and albuminuria with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999-2004.Significant association of rs13376333 in KCNN3 on chromosome 1q21 with atrial fibrillation in a Taiwanese population.Renal-related biomarkers and long-term mortality in the US subjects with different coronary risks.Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study.A triglyceride-raising APOA5 genetic variant is negatively associated with obesity and BMI in the Chinese population.Plasma levels of tumor necrosis factor-α and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase.Polygenetic regression model of renin-angiotensin system genes and the risk of coronary artery disease in a large angiographic population.Association of the variations in the HSD3β gene with primary aldosteronism.Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment.Prognostic factors of heart failure with preserved ejection fraction: a 12-year prospective cohort follow-up study.Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.Increased risk of co-morbid eye disease in patients with chronic renal failure: a population-based study.Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy.
P50
Q30391425-A5060015-7073-4902-BAD0-73CC5CB3CC63Q30809072-1FF17879-65F2-4E3A-BC7A-EC5E7221F278Q30886019-EC0E7CC3-320C-43BE-83F1-3D0BF6123554Q31058267-D7CECD78-3E07-4446-95DE-3413AC12134FQ33167473-0440D953-1743-4FB4-8E88-E644DB05B3CAQ33729836-7D0FAE16-D12C-4C4A-8F0C-3D07F5072069Q34722642-055EC978-A5E2-4CCB-9821-24BBFBBEF03FQ34776711-D86CBBF7-D708-42C5-B4DC-C4AF04DECC5AQ35086172-90CBDA5B-B058-40BC-A0EA-8C0F4C0630F3Q35909295-1F03747D-1D29-4D70-9856-28A5F14E0245Q36009320-1794D571-4F89-48A3-9A46-F609118F67B9Q36152894-200389ED-D9CC-4B5F-84F9-F641B9FA1C84Q36297961-A78E766C-2436-4F73-AFDB-12309263AEB1Q36456015-AF4D1B36-882B-44BD-8D28-E0DF4E3DAD85Q36542196-6812B897-6EE2-4998-96A7-9C277D8C6073Q36754362-76F0CF8F-47FC-4932-AAF2-37D620481D63Q37153884-4749B929-597D-4E2F-BB40-138D756C1347Q37676378-61CB05E1-9B68-448B-8496-AAC84E2838AFQ37727170-809C6CAB-121F-4E89-A253-CFD282DB9C09Q38906308-4A38E472-7C36-4773-95BE-31A95A919819Q39209784-B26DDAF2-4BD9-4617-9054-A23C7555C8F1Q39311954-01816AEB-0BC6-4FCB-BD0A-A926761D39B4Q39363829-F6103A8B-4F5E-4412-A617-D282B506D07DQ39653047-5E39754D-126C-4E13-BBB0-1C0B98514006Q40356660-09A730A7-8BDF-4152-BB7C-739FCD3B2823Q40591063-D3D2F3BF-B48D-4591-9E67-684A9D8AB65CQ42467533-F275052F-6EAF-46CA-B992-3D47E185544FQ43277565-F9D7F330-97E8-4289-872A-75207337F837Q43459422-08CBA4B7-0F16-4080-8C20-5E8358CCA1E0Q43501859-19B62EAC-CB4B-42DD-9E3F-10FF07E9C2DCQ44323356-CA8DE5D1-FF8F-47AF-BA90-22F49116CF48Q44442660-6D751878-EFEC-4E4B-BCFF-B4BB42B69ED8Q44753458-5303CFB7-3227-4B93-B999-2881203D4B60Q44831235-7CEC8F26-4DBB-487F-AE84-58E3CA795E3CQ45216829-09FE14DE-3909-4928-9CB3-D9E70853AC9BQ45400645-3DAA35C7-4362-476E-9C84-A36D773190F1Q46775782-E057D54D-FB8F-4D59-857A-949883894FF8Q47095887-C37C4698-45DC-4FDF-AACB-B2AAF5E4A6B4Q47793835-FD91BF34-B34F-45A1-90D8-3A4C430861E8Q48017667-F6581043-EA73-4613-B67A-22ED5AB505B6
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3867-150X
@en
name
Cho-Kai Wu
@ast
Cho-Kai Wu
@en
Cho-Kai Wu
@es
Cho-Kai Wu
@nl
type
label
Cho-Kai Wu
@ast
Cho-Kai Wu
@en
Cho-Kai Wu
@es
Cho-Kai Wu
@nl
prefLabel
Cho-Kai Wu
@ast
Cho-Kai Wu
@en
Cho-Kai Wu
@es
Cho-Kai Wu
@nl
P106
P1153
23020308600
P31
P496
0000-0002-3867-150X